Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.

Autor: Haist, Maximilian1,2,3 (AUTHOR) mhaist@uni-mainz.de, Stege, Henner1 (AUTHOR), Lang, Berenice Mareen1 (AUTHOR), Tsochataridou, Aikaterini1 (AUTHOR), Salzmann, Martin4 (AUTHOR), Mohr, Peter5 (AUTHOR), Schadendorf, Dirk6 (AUTHOR), Ugurel, Selma6 (AUTHOR), Placke, Jan-Malte6 (AUTHOR), Weichenthal, Michael7 (AUTHOR), Gutzmer, Ralf8 (AUTHOR), Leiter, Ulrike9 (AUTHOR), Kaatz, Martin10 (AUTHOR), Haferkamp, Sebastian11 (AUTHOR), Berking, Carola12 (AUTHOR), Heppt, Markus12 (AUTHOR), Tschechne, Barbara13 (AUTHOR), Schummer, Patrick14 (AUTHOR), Gebhardt, Christoffer15 (AUTHOR), Grabbe, Stephan1 (AUTHOR)
Zdroj: Cancers. Nov2022, Vol. 14 Issue 22, p5543. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje